PURPOSE: Keratoconus is a chronic, noninflammatory disease of the cornea with onset in
early adulthood. As these years are important to financial and social health, keratoconus may …

… Dr Kymes is a consultant for and receives research support from … Kymes held various
management and marketing positions with health care and managed care organizations. Dr Kymes…

PURPOSE: To investigate whether there is an association between complement factor H (CFH)
or LOC387715 genotypes with response to treatment with intravitreal bevacizumab for …

CT and PET are widely used to characterize solitary pulmonary nodules (SPNs). However,
most CT accuracy studies have been performed with outdated technology and methods, and …

Osteoarthritis (OA) is a common and disabling disease. Because of improved treatment of
chronic diseases and lower mortality from infectious diseases, the US population is aging, and …

Aims: To determine whether complement factor H (CFH) genotypes have a pharmacogenetic
effect on the treatment of exudative age-related macular degeneration (AMD) with …

PURPOSE:: To estimate the expected incremental lifetime cost of treatment of keratoconus
compared to the expected cost of the treatment of myopia. DESIGN:: Cost estimate from the …

Purpose: To describe a systematic review of population-based prevalence studies of visual
impairment (VI) and blindness worldwide over the past 32 years that informs the Global …

PURPOSE: The Ocular Hypertension Treatment Study (OHTS) demonstrated that medical
treatment of people with intraocular pressure (IOP) of ≥24 mm Hg reduces the risk of the …

OBJECTIVES: Medication discrepancies at the time of hospital discharge are common and
can harm patients. Medication reconciliation by pharmacists has been shown to prevent such …